1999
Failure to Improve Left Ventricular Function After Coronary Revascularization for Ischemic Cardiomyopathy Is Not Associated With Worse Outcome
Samady H, Elefteriades J, Abbott B, Mattera J, McPherson C, Wackers F. Failure to Improve Left Ventricular Function After Coronary Revascularization for Ischemic Cardiomyopathy Is Not Associated With Worse Outcome. Circulation 1999, 100: 1298-1304. PMID: 10491374, DOI: 10.1161/01.cir.100.12.1298.Peer-Reviewed Original ResearchConceptsVentricular functionIschemic cardiomyopathyGroup AHeart failure scoreLeft ventricular functionIschemic LV dysfunctionPoor patient outcomesB. Group ALack of improvementBaseline LVEFEffective revascularizationImproved LVEFCoronary revascularizationLV dysfunctionConsecutive patientsIntraoperative variablesPostoperative improvementCardiac deathLV functionPoor outcomeViable myocardiumLVEF assessmentIschemic myocardiumPatient outcomesWorse outcomes
1987
Long-term performance of the St. Jude Medical valve: low incidence of thromboembolism and hemorrhagic complications with modest doses of warfarin.
Kopf G, Hammond G, Geha A, Elefteriades J, Hashim S. Long-term performance of the St. Jude Medical valve: low incidence of thromboembolism and hemorrhagic complications with modest doses of warfarin. Circulation 1987, 76: iii132-6. PMID: 3621536.Peer-Reviewed Original ResearchConceptsSt. Jude Medical valveJude Medical valveModest dosesHemorrhagic complicationsLower incidenceValve failureLate cardiac deathStructural valve failureDouble valve replacementPercent of patientsOccurrence of thromboembolismHospital survivorsAnticoagulation regimenPerivalvular leakValve thrombosisValve replacementCardiac deathProthrombin timeMitral positionThromboembolismPatientsComplicationsThrombosisWarfarinIncidence